top of page

How New Zealand Is Rewiring Traditional Chinese Medicine

How New Zealand Is Rewiring Traditional Chinese Medicine Visual Media

New Zealand is quietly rewriting the rules of Traditional Chinese Medicine (TCM), a field that’s been brewing herbs the same way for 5,000 years. Enter Alpha Group, once a West Auckland garage project, now a global biotech heavyweight whose patented low-temperature extraction tech is stripping active compounds from plants, fungi, and fruits without destroying their potency.


The US$60 billion TCM sector is heading toward US$98 billion by 2032, and Alpha’s clean-tech system could be its long-overdue upgrade. Ginseng, reishi, astragalus - these ancient roots are now being re-engineered into consistent, ready-to-drink formulations not needing hours of boiling. Less waste, less energy, more efficacy, a rare mix in an industry known for ritual over rigour.


Backed by NZ$830 million in global infrastructure and R&D links between Auckland, Palmerston North, and Shanghai, Alpha is proving New Zealand can do more than export milk and meat. It can export precision and perhaps redefine what “traditional medicine” even means in a biotech century.



ENDS:

Comments


TOP STORIES

1/158
bottom of page